MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
MediWound Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026
$12.70+0.85 (+7.17%)
Close on Oct 19, 2026
- Market cap
- $167.72M
- P/E (TTM)
- –
- Dividend yield
- –
MediWound Ltd. cash flow statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- 19.2%
- Operating margin
- -149.0%
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 2.32
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 23.4%
Valuation
- P/E ratio
- –
- Price to sales
- 9.89
- Price to book
- –
- Dividend yield
- –